The work comes back in days instead of weeks — with every line validated
Hundreds of agents per question.
One knowledge graph.
Nothing unsourced.
01
Sources you can review
Review the sources behind the findings, including supporting passages where available. Reports distinguish source evidence from BIOPTIC's analysis and flag gaps that need further review.
02
Chinese-language research
We search Chinese patent filings, trial registries, and company disclosures, including records from the China National Intellectual Property Administration (CNIPA). Specialized sources such as PharmCube help us find and evaluate drug assets that may be harder to identify in English-language databases.
03
Pharma data sources
Our sources include SEC filings, FDA guidance, trial registries, scientific literature, and company reports. We standardize records for analysis and can connect compatible data providers your team already licenses.
04
Scheduled monitoring
Choose daily, weekly, or monthly updates for agreed assets and topics. Agents track new information on trials, patents, licensing deals, and regulatory developments, with source references for the changes.
05
Research in one workspace
Bring public sources, licensed data, and project documents into one workspace. Agents link drug assets, companies, trials, and supporting documents so your team can review the evidence together.
How the system is built
The system divides a research question into tasks, searches the relevant sources, and brings the findings together for review.
01
Parallel research
Agents work on different parts of the question at the same time.
02
Relevant sources
Each agent uses the search tools and databases needed for its research task.
03
Focused tasks
Agents investigate specific questions and return findings with source references.
04
Connected evidence
A knowledge graph links assets, companies, trials, and supporting documents.